March 25, 2025: Food & Drug Administration Says Trulicity Shortage Still Active as Lawsuits Increase On February 21, 2025, the Food & Drug Administration lifted many of the semaglutide injection shortages
We review whether the records support allegations seen in GLP-1 litigation involving severe digestive injuries and vision-related complaints, while accounting for individual risk factors and alternative causes
Its use is being popularized by the lay press and in some cases there has been excessive usage of glutathione by the public leading to some national drug control authorities in South East Asia restricting its sale and usage
Skipping on collagen peptides during this time might leave you feeling less than your best
[DOI] [PubMed] [Google Scholar] 60.Miao R., Yang G., Miao Y., Mei Y., Hong J., Zhao C., Zhu L
With the rise in several lawsuits, thorough medical records have become increasingly important in establishing liability